AXIN1 and hepatocellular carcinoma: Characterizations of human HCC cultures identified Axin1 mutations in many of the cell lines and a corresponding increase in the DNA-binding activities of TCF/LEF (T-cell factor/Lymphoid enhancer-binding factor 1) and β-catenin [53].